These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4020537)

  • 21. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
    Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
    Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
    [No Abstract]   [Full Text] [Related]  

  • 22. A death due to 4-bromo-2,5-dimethoxyamphetamine.
    Winek CL; Collom WD; Bricker JD
    Clin Toxicol; 1981 Mar; 18(3):267-71. PubMed ID: 7237958
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
    Dyer DC
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromo-DMA: the Australasian hallucinogen?
    Buhrich N; Morris G; Cook G
    Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 2,5-dimethoxy-4-methylamphetamine on the behavior of rats in competition for food.
    Uyeno ET
    Int Pharmacopsychiatry; 1972; 7(1-4):244-8. PubMed ID: 4681210
    [No Abstract]   [Full Text] [Related]  

  • 27. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
    Jacob JN; Nichols DE
    J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
    Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiovascular effects of 2,5-dimethoxy-4-methyl amphetamine (S.T.P. or D.O.M.)].
    Boissier JR; Advenier C; Giudicelli JF
    Therapie; 1972; 27(6):989-99. PubMed ID: 4661229
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
    Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
    Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
    McKenna DJ; Saavedra JM
    Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
    [No Abstract]   [Full Text] [Related]  

  • 34. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole.
    Zweig JS; Castagnoli N
    J Med Chem; 1974 Jul; 17(7):747-9. PubMed ID: 4836406
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
    Buyniski JP; Smith ML; Bierwagen ME
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of rigid analogues to probe hallucinogen receptors.
    Nichols DE; Weintraub HJ; Pfister WR; Yim GK
    NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
    [No Abstract]   [Full Text] [Related]  

  • 38. 4-Bromo-2,5-dimethoxyphenethylamine: identification of a new street drug.
    Ragan FA; Hite SA; Samuels MS; Garey RE
    J Anal Toxicol; 1985; 9(2):91-3. PubMed ID: 3990254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
    Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
    J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on hallucinogens. IV. Synthesis of 2,5-dimethoxy-4-methylamphetamine (STP) (author's transl)].
    Ono M; Shimamine M; Takahashi K
    Eisei Shikenjo Hokoku; 1973; 91(0):41-44. PubMed ID: 4800136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.